Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jaanika Narits"'
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss , Pp 83-87 (2020)
We report on a 67-year old male with advanced stage lung adenocarcinoma (initially PD-L1 negative, EGFR and ALK negative) diagnosed in 2014. The patient received 4 lines of palliative chemotherapy from 2014 to 2017, however the disease progressed. In
Externí odkaz:
https://doaj.org/article/8f6c46212ec241e5995ea7589b127654
Autor:
Marju Kase, Darja Lavogina, Ave Minajeva, Hannes Tamm, Jana Jaal, Annett Vapper, Hardi Aaspõllu, Marika Saar, Tõnu Vooder, Laura Mägi, Jaanika Narits, Maksim Buldakov
Publikováno v:
Molecular and Clinical Oncology
Immunotherapy using immune checkpoint inhibitors has demonstrated durable responses and has significantly improved survival in patients with non-small cell lung cancer (NSCLC). Moreover, immunotherapy is increasingly used in combination with cytotoxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf7b90adfd130bac44eb7a7a962563e
https://pubmed.ncbi.nlm.nih.gov/34462666
https://pubmed.ncbi.nlm.nih.gov/34462666
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 22, Iss, Pp 83-87 (2020)
Clinical and Translational Radiation Oncology, Vol 22, Iss, Pp 83-87 (2020)
Highlights: • Radiotherapy induced high PD-L1 expression in initially PD-L1 negative metastatic nsclc patient. • High PD-L1 expression was also evident in gut metastasis that developed after radiotherapy. • Due to high PD-L1 expression, immunot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaad4d8da21a2200e9386d69760af4ee
https://pubmed.ncbi.nlm.nih.gov/32300664
https://pubmed.ncbi.nlm.nih.gov/32300664